# Addition of Heparin to Taurolock-TM CLS in HD Patients With TCC Dose it Improve Catheter Patency Problems ?

> **NCT00749619** · PHASE3 · COMPLETED · sponsor: **Western Galilee Hospital-Nahariya**

## Conditions studied

- End Stage Renal Disease
- Hemodialysis

## Interventions

- **OTHER:** Catheter Lock Solution Taurolidine and Citrate
- **OTHER:** Catheter Lock Solution :Taurolidine and Citrate and Heparin
- **OTHER:** Catheter Lock Solution : Heparin

## Key facts

- **NCT ID:** NCT00749619
- **Lead sponsor:** Western Galilee Hospital-Nahariya
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** — (—)
- **Last updated:** 2008-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00749619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00749619, "Addition of Heparin to Taurolock-TM CLS in HD Patients With TCC Dose it Improve Catheter Patency Problems ?". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00749619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*